ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Innate Pharma

Innate Pharma (IPH)

1.92
-0.032
( -1.64% )
更新日時: 20:21:44

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
1.92
買値
1.92
売値
1.94
出来高
82,751
1.902 日の範囲 1.988
1.332 52 週間の範囲 2.79
時価総額
前日終値
1.952
始値
1.958
最終取引時間
20:21:44
財務取引量
-
VWAP
-
平均取引量 (3 か月)
163,595
発行済株式数
318,170,508
配当利回り
-
PER
-81.51
1 株当たり利益 (EPS)
-0.02
歳入
61.64M
純利益
-7.57M

Innate Pharma について

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Marseille, Bouches-du-rhone, Fra
設立
-
Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the ユーロネクスト with ticker IPH. The last closing price for Innate Pharma was 1.95 €. Over the last year, Innate Pharma shares have traded in a share price range of 1.332 € to 2.79 €.

Innate Pharma currently has 318,170,508 shares in issue. The market capitalisation of Innate Pharma is 621.07 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -81.51.

IPH 最新ニュース

Innate Pharma annonce le traitement du premier patient dans l’essai de Phase 1 évaluant IPH4502, son conjugué anticorps-médicament ciblant Nectine-4, dans une sélection de tumeurs solides avancées

IPH4502 est un nouveau conjugué anticorps-médicament ciblant Nectine-4 et différencié à base d’exatecan, un inhibiteur de topoisomérase I, comme agent cytotoxique. Regulatory News: Innate Pharma...

Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York

Innate Pharma to highlight IPH4502, its lead Nectin-4 Antibody Drug Conjugate (ADC) program at clinical stage Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or...

Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 31 décembre 2024

Regulatory News: Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l’Autorité des marchés financiers (l’« AMF »), Innate Pharma SA (Euronext Paris : IPH...

Innate Pharma annonce une stratégie de transformation pour accélérer sa croissance

 Une stratégie axée sur le développement clinique précoce de molécules propriétaires présentant un potentiel en monothérapie : Stimuler l’innovation grâce à la plateforme ANKET® produisant des «...

Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its management will present and host 1x1 meetings at the 43rd Annual J.P...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.18410.5990783411.7362.051.7141217091.88056457DE
40.073.783783783781.852.051.7021088151.80358941DE
120.42281.52.491.3321635951.78094327DE
26-0.08-422.491.3321001801.8156629DE
52-0.425-18.12366737742.3452.791.332837062.00776673DE
156-1.456-43.12796208533.3763.81.3321306622.60343488DE
260-4.655-70.79847908756.5757.3251.3322448203.75700891DE

IPH - Frequently Asked Questions (FAQ)

What is the current Innate Pharma share price?
The current share price of Innate Pharma is 1.92 €
How many Innate Pharma shares are in issue?
Innate Pharma has 318,170,508 shares in issue
What is the market cap of Innate Pharma?
The market capitalisation of Innate Pharma is EUR 621.07M
What is the 1 year trading range for Innate Pharma share price?
Innate Pharma has traded in the range of 1.332 € to 2.79 € during the past year
What is the PE ratio of Innate Pharma?
The price to earnings ratio of Innate Pharma is -81.51
What is the cash to sales ratio of Innate Pharma?
The cash to sales ratio of Innate Pharma is 10.02
What is the reporting currency for Innate Pharma?
Innate Pharma reports financial results in EUR
What is the latest annual turnover for Innate Pharma?
The latest annual turnover of Innate Pharma is EUR 61.64M
What is the latest annual profit for Innate Pharma?
The latest annual profit of Innate Pharma is EUR -7.57M
What is the registered address of Innate Pharma?
The registered address for Innate Pharma is 117 AVENUE DE LUMINY, BP 30191, MARSEILLE, BOUCHES-DU-RHONE, 13009
What is the Innate Pharma website address?
The website address for Innate Pharma is www.innate-pharma.com
Which industry sector does Innate Pharma operate in?
Innate Pharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ALNMGNetMedia Group
2.34 €
(67.14%)
15.45k
ALAGOEPango SA
0.383 €
(20.44%)
4.94M
MLNMAMiguet Et Associes
0.08 €
(14.29%)
415
ALMASMastrad
0.0262 €
(13.91%)
10.99M
ALRGRRougier
17.80 €
(10.56%)
3.69k
BIODSBiosynex DS
0.0079 €
(-61.84%)
241.77k
ALNEVNeovacs
0.22 €
(-24.14%)
83.32k
ALTROTronic s Microsystems
4.10 €
(-23.36%)
39
ALVIOValerio Therapeutics
0.0618 €
(-20.46%)
1.05M
TUVDSBio UV Group DS
0.04 €
(-20.00%)
1.03M
ATOAtos SE
0.0021 €
(0.00%)
55.07M
BCPBanco Comercial Portugues SA
0.4933 €
(-0.22%)
23.04M
ALMASMastrad
0.0262 €
(13.91%)
10.99M
ALNRGEnergisme SA
0.0034 €
(6.25%)
6.06M
ALHPIHopium SA
0.003 €
(3.45%)
5.02M